Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuo Taguchi

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 18, 2011
Clinical implications of interleukin-18 levels in pediatric patients with Mycoplasma pneumoniae pneumoniaTomohiro Oishi, Mitsuo Narita, Kou Matsui, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 12, 2002
Phase II study of paclitaxel with 3-h infusion in patients with advanced gastric cancerKensei Yamaguchi, Masahiro Tada, Noboru Horikoshi, et al.
International Journal of Clinical Oncology|February 25, 2005
A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumorsToshiaki Saeki, Shigemitsu Takashima, Masanori Terashima, et al.
Oncology|March 13, 2008
Phase II study of a combination of irinotecan and S-1 in patients with advanced gastric cancer (OGSG0002)Noriya Uedo, Hiroyuki Narahara, Ryu Ishihara, et al.
Breast Cancer (Tokyo, Japan)|November 20, 2004
A phase II study of S-1 in patients with metastatic breast cancer--a Japanese trial by the S-1 Cooperative Study Group, Breast Cancer Working GroupToshiaki Saek, Shigemitsu Takashima, Muneaki Sano, et al.
Japanese Journal of Clinical Oncology|September 6, 2005
Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced gastric cancer (OGSG 0002)Hiroya Takiuchi, Hiroyuki Narahara, Toshimasa Tsujinaka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 13, 2006
[A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting]Hideo Inaji, Katsuji Sakai, Takahiro Oka, et al.
International Journal of Clinical Oncology|July 12, 2002
Phase I studies of nogitecan hydrochloride for JapaneseKunihiko Kobayashi, Mitsunori Hino, Masahiro Fukuoka, et al.
Anticancer Research|May 1, 2007
Multicenter phase II study of irinotecan plus bolus fluorouracil/l-leucovorin for metastasic colorectal cancerHideyuki Mishima, Masakazu Ikenaga, Hideyuki Ishida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 11, 2006
[Pharmacokinetics of S-1]Koichi Hirata, Noboru Horikoshi, Kazusaku Tominaga, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 18, 2011
Clinical implications of interleukin-18 levels in pediatric patients with Mycoplasma pneumoniae pneumoniaTomohiro Oishi, Mitsuo Narita, Kou Matsui, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 12, 2002
Phase II study of paclitaxel with 3-h infusion in patients with advanced gastric cancerKensei Yamaguchi, Masahiro Tada, Noboru Horikoshi, et al.
International Journal of Clinical Oncology|February 25, 2005
A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumorsToshiaki Saeki, Shigemitsu Takashima, Masanori Terashima, et al.
Oncology|March 13, 2008
Phase II study of a combination of irinotecan and S-1 in patients with advanced gastric cancer (OGSG0002)Noriya Uedo, Hiroyuki Narahara, Ryu Ishihara, et al.
Breast Cancer (Tokyo, Japan)|November 20, 2004
A phase II study of S-1 in patients with metastatic breast cancer--a Japanese trial by the S-1 Cooperative Study Group, Breast Cancer Working GroupToshiaki Saek, Shigemitsu Takashima, Muneaki Sano, et al.
Japanese Journal of Clinical Oncology|September 6, 2005
Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced gastric cancer (OGSG 0002)Hiroya Takiuchi, Hiroyuki Narahara, Toshimasa Tsujinaka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 13, 2006
[A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting]Hideo Inaji, Katsuji Sakai, Takahiro Oka, et al.
International Journal of Clinical Oncology|July 12, 2002
Phase I studies of nogitecan hydrochloride for JapaneseKunihiko Kobayashi, Mitsunori Hino, Masahiro Fukuoka, et al.
Anticancer Research|May 1, 2007
Multicenter phase II study of irinotecan plus bolus fluorouracil/l-leucovorin for metastasic colorectal cancerHideyuki Mishima, Masakazu Ikenaga, Hideyuki Ishida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 11, 2006
[Pharmacokinetics of S-1]Koichi Hirata, Noboru Horikoshi, Kazusaku Tominaga, et al.
Pageof 4